Scinai Immunotherapeutics regains compliance with Nasdaq listing rule Source: Seekingalpha
Browsing: listing
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements Source: Seekingalpha
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…